- Home
- GALT vs IDR Comparison
GALT vs IDR Comparison
Compare GALT & IDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GALT
- IDR
- Stock Information
- Founded
- GALT 2000
- IDR 1996
- Country
- GALT United States
- IDR United States
- Employees
- GALT N/A
- IDR N/A
- Industry
- GALT Biotechnology: Pharmaceutical Preparations
- IDR Precious Metals
- Sector
- GALT Health Care
- IDR Basic Materials
- Exchange
- GALT Nasdaq
- IDR Nasdaq
- Market Cap
- GALT 147.8M
- IDR 174.3M
- IPO Year
- GALT N/A
- IDR N/A
- Fundamental
- Price
- GALT $2.12
- IDR $11.34
- Analyst Decision
- GALT Strong Buy
- IDR Strong Buy
- Analyst Count
- GALT 1
- IDR 1
- Target Price
- GALT $11.00
- IDR $14.00
- AVG Volume (30 Days)
- GALT 549.5K
- IDR 209.0K
- Earning Date
- GALT 11-13-2024
- IDR 11-04-2024
- Dividend Yield
- GALT N/A
- IDR N/A
- EPS Growth
- GALT N/A
- IDR 344.27
- EPS
- GALT N/A
- IDR 0.52
- Revenue
- GALT N/A
- IDR $21,955,008.00
- Revenue This Year
- GALT N/A
- IDR $100.42
- Revenue Next Year
- GALT N/A
- IDR $4.80
- P/E Ratio
- GALT N/A
- IDR $22.17
- Revenue Growth
- GALT N/A
- IDR 64.93
- 52 Week Low
- GALT $1.56
- IDR $5.58
- 52 Week High
- GALT $4.27
- IDR $18.35
- Technical
- Relative Strength Index (RSI)
- GALT 39.78
- IDR 40.15
- Support Level
- GALT $1.80
- IDR $12.05
- Resistance Level
- GALT $2.36
- IDR $12.86
- Average True Range (ATR)
- GALT 0.23
- IDR 0.67
- MACD
- GALT -0.03
- IDR 0.04
- Stochastic Oscillator
- GALT 26.89
- IDR 11.27
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
About IDR Idaho Strategic Resources Inc.
Idaho Strategic Resources Inc is a vertically integrated, operating junior mining company. It produces gold at the Golden Chest Mine. In addition to gold and gold production, the company maintains a strategic and domestic presence in the Critical Minerals sector and is focused on advancing its officially recognized Lemhi Pass, Diamond Creek, and Roberts Rare Earth Element projects in central Idaho.